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Available online 18 March 2008Mutations in human Retinol Dehydrogenase 12 (RDH12) are known to cause photoreceptor cell death but the
physiological function of RDH12 in photoreceptors remains poorly understood. In vitro, RDH12 recognizes
both retinoids and medium-chain aldehydes as substrates. Our previous study suggested that RDH12 protects
cells against toxic levels of retinaldehyde and retinoic acid [S.A. Lee, O.V. Belyaeva, I.K. Popov, N.Y. Kedishvili,
Overproduction of bioactive retinoic acid in cells expressing disease-associated mutants of retinol
dehydrogenase 12, J. Biol. Chem. 282 (2007) 35621–35628]. Here, we investigated whether RDH12 can also
protect cells against highly reactive medium-chain aldehydes. Analysis of cell survival demonstrated that
RDH12 was protective against nonanal but not against 4-hydroxynonenal. At high concentrations, nonanal
inhibited the activity of RDH12 towards retinaldehyde, suggesting that nonanal wasmetabolized by RDH12. 4-
Hydroxynonenal did not inhibit the RDH12 retinaldehyde reductase activity, but it strongly inhibited the
activities of lecithin:retinol acyl transferase and aldehyde dehydrogenase, resulting in decreased levels of
retinyl esters and retinoic acid and accumulation of unesteriﬁed retinol. Thus, the results of this study showed
that RDH12 is more effective in protection against retinaldehyde than against medium-chain aldehydes, and
that medium-chain aldehydes, especially 4-hydroxynonenal, severely disrupt cellular retinoid homeostasis.
Together, these ﬁndings provide a new insight into the effects of lipid peroxidation products and the impact of
oxidative stress on retinoid metabolism.
© 2008 Elsevier B.V. All rights reserved.Keywords:
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HumanRetinol Dehydrogenase 12 (RDH12) is anNADP+-dependent
oxidoreductase that acts exclusively in the reductive direction in the
cells [1]. Kinetic analysis suggests that RDH12 recognizes retinalde-
hyde as well as medium-chain aldehydes as substrates [2]. Photo-
receptors, which are the main site of RDH12 expression in human
tissues [2], contain high levels of both types of substrates for RDH12.
All-trans-retinaldehyde is produced by photoisomerization of 11-cis-
retinaldehyde covalently bound to rod and cone opsins and can
theoretically reach concentrations as high as 3 mM depending on
ambient light intensity [3]. Photoreceptors are also extremely rich in
unsaturated docosahexaenoic acid (22:6, n — 3) [4,5], which can
readily undergo peroxidic oxidation to medium-chain aldehydes.
Under the conditions of constant illumination and high oxygenand Molecular Genetics, School
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l rights reserved.pressure, concentrations of these aldehydes in photoreceptors can
reach millimolar range [6].
Bothmedium-chain aldehydes and retinoids exert potent biological
activities that can impact photoreceptor viability. For example, one of
the most abundant and toxic medium-chain aldehydes, 4-hydroxyno-
nenal (4-HNE), combines spontaneously with glutathione and with
cysteine, histidine, and lysine residues in cellular proteins, causing a
variety of cytotoxic and genotoxic effects [7]. High levels of all-trans-
retinaldehyde are also cytotoxic and, in addition, can give rise to
bioactive all-trans-retinoic acid [8], which was shown to accelerate
photoreceptor cell death by apoptosis [9,10].
Mutations in RDH12 have been linked to severe early onsetmacular
degeneration [11–14], but the molecular basis of photoreceptor cell
death in patients carrying mutations in RDH12 has not yet been
resolved. Our recent study suggested that RDH12 may function to
protect photoreceptors against toxic levels of all-trans-retinaldehyde
and all-trans-retinoic acid [1]. Whether RDH12 can also play a role in
protection of cells against medium-chain aldehydes remains
unknown. Here, we investigated the contribution of RDH12 to cell
protection against medium-chain aldehydes and examined the effects
of medium-chain aldehydes on RDH12 retinaldehyde reductase
activity and retinoid metabolism. The results of this study shed new
light on the function of RDH12 and the impact of lipid peroxidation
products on the overall retinoid homeostasis.
Fig. 1. Role of RDH12 in protection against nonanal- or 4-HNE-induced cell death.
A, Western blot analysis of RDH12 expression. HEK293 cells were transiently transfected
with empty vector (mock) or an expression construct for RDH12 (RDH12). RDH12
protein was detected using rabbit polyclonal antibodies against RDH12 (1:10,000
dilution) [1]. The blots were re-stained for β-actin using anti-β-actin monoclonal
antibody (Sigma-Aldrich) at a 1:5000 dilution to control for protein loading. B–D, MTT
assays. RDH12-transfected cells (RDH12) and mock-transfected cells (mock) were
incubatedwith varied concentrations of 4-hydroxynonenal (B) or nonanal (C) for 24 h; or
with a ﬁxed concentration of nonanal (200 µM) for different time intervals (D). Cell
viability was determined by MTT assay and the optical density (OD) was monitored at
595 nm using ELISA plate reader. Data are mean±SD of four independent experiments.
Statistical analysis was done using two-tailed unpaired Student's t test comparing
RDH12-transfected cells to mock-transfected cells.
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2.1. Cell viability assay
HEK293 cells seeded in a 24-well plate were transiently transfected with RDH12/
pIRESneo or empty pIRESneo plasmid (Clontech, Mountain View, CA) using Lipofectamine
2000 (Invitrogen, Carlsbad, CA), according to the manufacturer's protocol. Construction of
RDH12/pIRESneo vector and Western blot analysis of RDH12 expression in the cells was
describedpreviously [1]. Twenty-fourhours after transfection, freshmedia containingvarious
concentrations (0–200 µM) of nonanal or 4-HNE (four-replicatewells for each concentration)
wasadded. Cellswere incubatedwithaldehydes for indicated time intervals. Cell viabilitywas
assessed using a modiﬁed MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide) (Sigma-Aldrich) assay [15]. Medium containing 0.5 mg/ml MTT solution was
added to eachwell andplateswere incubated at 37 °C for 2h. Themediumwasdecanted, and
the reactionwas stopped by the addition of 0.5ml dimethyl sulfoxide. Plates were incubated
at37 °C for severalminutes, and0.2mlof the solubilized formazan solutionwas transferred to
a 96-well plate. The absorbance was read at 595 nm using an ELISA plate reader.
2.2. Analysis of RDH12 activity in HEK293 cells
HEK293 cells plated in 35 mm dishes were transiently transfected with RDH12/
pIRESneo or empty pIRESneo plasmid as described above. Two days after transfection,
the cells were incubated with 10 μM all-trans-retinaldehyde (Sigma-Aldrich, St. Louis,
MO) in the presence of 4-HNE or nonanal (100 or 200 μM). 4-HNE and nonanal were
added to cell culture media from ethanol stock solutions; the concentration of ethanol
in the media did not exceed 1%. Retinoids were extracted into hexane from media and
cells under red light and separated by normal phase high performance liquid
chromatography (HPLC) usingWaters Alliance SeparationModule and 2996 Photodiode
Array Detector (Waters Corp., Milford, MA, USA) [2]. Peaks were identiﬁed by
comparison to retention times of retinoid standards and evaluation of wavelength
maxima and quantiﬁed as described previously [2].
2.3. Inhibition of lecithin:retinol acyltransferase activity
Human lecithin:retinol acyltransferase (LRAT) was expressed in Sf9 cells as described
elsewhere [16] and the microsomal preparation of LRAT was obtained by differential
centrifugation [16]. The activity of LRAT in the presence of varied concentrations of 4-HNE
or nonanal was determined by monitoring the formation of retinyl esters from all-trans-
retinol and dipalmitoylphosphatidylcholine (DPPC). The reactions were carried out in
90mMKH2PO4 (pH 7.4) and 40mMKCl at 37 °C for 15min and stopped by the addition of
methanol. Retinoids were extracted twice with 4 ml of hexane and analyzed by normal
phase HPLC as described previously [16]. The IC50 value for the inhibition of LRAT activity
was calculated using GraFit (Erithacus Software Ltd., Horley, Surrey, U.K.).
2.4. RT-PCR analysis of ALDH1A1 and ALDH1A2 expression in HEK293 cells
Total RNA was isolated from HEK293 cells using RNeasy Mini Kit (Qiagen Inc.
Valencia, CA). One microgram of total RNA was used to perform reverse transcription
(RT) according to the manufacturer's protocol (Promega Inc. Madison, WI). The
ampliﬁcation of cDNAwas performed for 1 cycle at 94 °C for 4min followed by 35 cycles
at 94 °C for 40 s, 60 °C for 40 s, 72 °C for 40 s and 1 cycle at 72 °C for 10 min. The PCR
primers were designed to span an intron according to GenBank sequences of human
ALDH1A1 and ALDH1A2, and were as follows: ALDH1A1, forward 5′- CCG CAA GAC AGG
CTT TTC AGA -3′ and reverse 5′- AAG ATG CCA CGT GGA GAG CAG -3′; ALDH1A2,
forward 5′- GTG GAA CGG GAC AGG GCA GT -3′ and reverse 5′- CTT TCG GCC CAG TCC
TTT GC -3′. The RT-PCR products were analyzed by agarose (1.5%) gel electrophoresis
with ethidium bromide staining. The expected size of PCR product was 429 bp and
856 bp for ALDH1A1 and ALDH1A2, respectively.
2.5. Inhibition of retinaldehyde dehydrogenase activity
Puriﬁed recombinant human aldehyde dehydrogenase ALDH1A1 and the corre-
sponding cDNA expression vector were a kind gift from Dr. Henry Weiner (Purdue
University). The activity of ALDH1A1 in the presence of varied concentrations of
nonanal and 4-HNE was determined by monitoring the formation of retinoic acid from
all-trans-retinaldehyde using HPLC as described above. The reactions were carried out
in 90 mM KH2PO4 (pH 7.4) and 40 mM KCl at 37 °C for 15 min and stopped by the
addition of methanol. The IC50 values for inhibition of ALDH1A1 retinaldehyde
dehydrogenase activity were calculated using GraFit.
2.6. Statistical analysis
Statistical signiﬁcance was determined by a two-tailed unpaired Student's t test
using GraphPad Prism version 4.0 for Windows (GraphPad Software, San Diego, CA).
pb0.05 was considered statistically signiﬁcant.
3. Results
To determinewhether RDH12 plays a role in cell protection against
lipid-derived aldehydes, we selected two medium-chain aldehydes,nonanal and 4-HNE, known to be substrates for RDH12 in vitro [2].
HEK293 cells transfected with either RDH12/pIRESneo or empty
vector (mock-transfected) were incubated with different concentra-
tions of 4-HNE or nonanal and cell viability was determined using
Fig. 3. Effect of 4-HNE on RDH12 activity and retinoid metabolism. RDH12-transfected
cells (+RDH12) and mock-transfected cells (−RDH12) were incubated with 10 μM all-
trans-retinaldehyde for 3 h in the absence (none) or presence of 4-HNE. The products of
retinaldehyde metabolism were analyzed by normal phase HPLC. Abbreviations are as
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Western blot analysis (Fig. 1A). There was no difference in survival of
RDH12-expressing cells versus RDH12-lacking cells upon exposure to
4-HNE (Fig. 1B). However, a statistically signiﬁcant (pb0.05) increase
in survival of RDH12-expressing cells was observed after incubation of
cells with high concentrations (150–200 μM) of nonanal (Fig. 1C, D).
Thus, RDH12 protected the cells against nonanal-induced toxicity but
was ineffective against 4-HNE, suggesting that, in living cells, RDH12
was able to metabolize and eliminate nonanal, but not 4-HNE.
To obtain further evidence that nonanal was utilized as a substrate
by RDH12 in the cells, we examined the effect of nonanal on RDH12
activity toward retinaldehyde. Nonanal was added to RDH12/pIRES-
neo-transfected and mock-transfected cells together with retinalde-
hyde and the products of retinaldehyde metabolismwere analyzed by
HPLC after extraction from cells andmedium. The presence of nonanal
in cell culture medium resulted in signiﬁcantly decreased production
of retinol from retinaldehyde in the cells expressing RDH12 (1.5-fold at
100 μM, p=0.004) but not in mock-transfected cells (Fig. 2), suggesting
that nonanal caused a decrease in RDH12 retinaldehyde reductase
activity. The extent of inhibition by nonanal was concentration-
dependent: 200 μM nonanal exhibited a 1.5-fold greater inhibition
than 100 μM nonanal (Fig. 2). The inhibition of RDH12 retinaldehyde
reductase activity by nonanal was consistentwith nonanal acting as an
alternative substrate for RDH12. Nonanal also inhibited the biosynth-
esis of retinoic acid but had little or no effect on retinyl esters (Fig. 2).
In contrast to nonanal, 4-HNE had a dramatic effect on the overall
retinoidmetabolism in the cells but did not appear to affect the RDH12
activity. The presence of 4-HNE in cell culture medium resulted in an
increased rather than a decreased production of retinol from
retinaldehyde (1.3-fold, p=0.02) (Fig. 3). At the same time, 4-HNEFig. 2. Effect of nonanal on RDH12 activity and retinoid metabolism. RDH12-transfected
cells (+RDH12) and mock-transfected cells (−RDH12) were incubated with 10 μM all-
trans-retinaldehyde for 3 h in the absence (none) or presence of nonanal. The products
of retinaldehyde metabolism were analyzed by normal phase HPLC as described in
Materials and methods. Data shown represent combined retinoids extracted from
medium and cells. RE, retinyl esters; ROL, retinol; RA, retinoic acid. Data are mean±SD
of ﬁve independent experiments. Statistical analysis was done using two-tailed
unpaired Student's t test. ⁎pb0.05; ⁎⁎pb0.01.
in Fig. 2. Data are mean±SD of three independent experiments. Statistical analysis was
done using two-tailed unpaired Student's t test. ⁎pb0.05; ⁎⁎pb0.01.caused a signiﬁcant drop in the cellular levels of retinoic acid and
retinyl esters in both RDH12-transfected and mock-transfected cells
(3–4-fold and 3-fold, respectively, at 100 μM, pb0.001) (Fig. 3),
suggesting that 4-HNE inhibits the activities of endogenous retinol
esterases and retinaldehyde dehydrogenases.
To obtain direct evidence that 4-HNE inhibits the biosynthesis of
retinyl esters, we examined the effect of 4-HNE on the activity of a
major retinol-esterifying enzyme, LRAT, known to be present in
HEK293 cells [17]. LRAT was expressed in Sf9 cells using the
Baculovirus expression system and Sf9 microsomes containing the
recombinant LRAT were isolated for activity assays. Analysis of LRAT
activity in the presence of increasing concentrations of 4-HNE showed
that 4-HNE inhibited LRAT activity with the IC50 value of 37 μM,Fig. 4. Inhibition of LRAT activity by nonanal and 4-HNE. LRAT-containing microsomes
were incubated with retinol (2 μM) and DPPC (200 μM) in the presence of 0–200 μM
nonanal (○) or 4-HNE (●). The formation of retinyl esters was monitored by normal
phase HPLC. Data shown are representative of three independent experiments.
Fig. 5. Inhibition of ALDH activity by nonanal and 4-HNE. A, RT-PCR analysis of
ALDH1A1 and ALDH1A2 expression in HEK293 cells. MW st., molecular weight
standards. B, Puriﬁed human ALDH1A1 was incubated with retinaldehyde (5 μM) and
NAD+ (1 mM) in the presence of 0–200 μM nonanal or 4-HNE. The amount of produced
retinoic acid was determined by HPLC as described under Materials and methods. Data
shown are representative of three independent experiments.
Fig. 6. Retinoid metabolic pathways. RE, retinyl esters; ROL, retinol; RAL, retinaldehyde;
RA, retinoic acid. The arrows pointing from ROL to RE and from RAL to RA are crossed (×)
to indicate the inhibition of LRAT and ALDH1A1 activities by 4-HNE.
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comparison, nonanal was a much weaker inhibitor and did not
decrease the activity of LRAT below 70% at the highest concentration
used (200 μM) (Fig. 4). Strong inhibition of LRAT activity by 4-HNE and
the lack of signiﬁcant inhibition by nonanal in vitrowere in agreement
with the effects of 4-HNE and nonanal on retinyl ester biosynthesis in
the cells (Figs. 2 and 3).
To determine whether medium-chain aldehydes inhibit the
activity of retinaldehyde dehydrogenase, we examined which reti-
noid-active aldehyde dehydrogenases are expressed in HEK293 cells.
RT-PCR analysis showed that HEK293 cells express both human
cytosolic ALDH1A1 (also known as RALDH1) [18,19] and ALDH1A2
(known as RALDH2) [20] (Fig. 5A). One of the enzymes, ALDH1A1, was
chosen as a model for investigation of the effect of aldehydes on its
retinaldehyde dehydrogenase activity.
Recombinant humanHis6-tagged ALDH1A1was expressed in E. coli
and puriﬁed using Ni2+-afﬁnity chromatography [21]. ALDH1A1 was
incubated with retinaldehyde in the presence of increasing concentra-
tions of nonanal or 4-HNE and the formation of retinoic acid was
analyzed by HPLC. Both nonanal and 4-HNE strongly inhibited
ALDH1A1-catalyzed oxidation of retinaldehyde with the IC50 values
of 11 μM and 14 μM, respectively (Fig. 5B). Inhibition of ALDH1A1
activity by nonanal and 4-HNE was in agreement with the reduced
levels of retinoic acid in RDH12-transfected andmock-transfected cells
treated with the medium-chain aldehydes.
4. Discussion
The results of this study demonstrate that RDH12 can protect cells
against nonanal-associated toxicity but not against 4-HNE because, in
contrast to 4-HNE, nonanal appears to be metabolized by RDH12 in the
cells. These results correlate well with the in vitro catalytic properties of
RDH12. Catalytic efﬁciencyofRDH12 for the reductionof nonanal is ~30-
fold greater than that for the reduction of 4-HNE [2]. While 4-HNE does
not appear to inhibit the retinaldehyde reductase activity of RDH12, it
profoundly affects the overall retinoid homeostasis in the cells by
inhibiting the retinol esteriﬁcation and retinoic acid biosynthesis. Theﬁnding that 4-HNE inhibits the activities of both ALDH1A1 and LRAT
offers an explanation for the surprising increase in retinol levels
observed in the cells incubated with 4-HNE: inhibition of retinaldehyde
oxidation to retinoic acid by ALDH results in an increased ﬂux of
retinaldehyde through retinaldehyde reductases and, therefore, an
increased biosynthesis of retinol, whereas the inhibition of LRATactivity
further raises the levels of cellular retinol by blocking its conversion to
retinyl esters (Fig. 6).
The inhibition of retinaldehyde oxidation to retinoic acid in tissue
homogenates by 4-HNE has been observed by others [22,23], but the
inhibitory effect of 4-HNE on retinol esteriﬁcation, to our knowledge,
has not been reported previously. This ﬁnding may offer a new insight
into the molecular mechanism of liver retinyl ester depletion in
alcoholic liver disease. Ethanol-induced depletion of hepatic vitamin A
stores is one of the characteristic features of alcoholic liver injury, both
in experimental animals and in humans [reviewed in Refs. 24–26].
Severalmechanisms have been suggested to explain this phenomenon,
including increased mobilization of vitamin A from the liver and
enhanced catabolism of vitamin A in the liver and other organs [24–
26]. However, alcohol consumption is also associated with enhanced
lipid peroxidation, protein carbonyl formation, production of reactive
oxygen species (ROS), and decreases in hepatic antioxidant defense,
especially GSH [reviewed in Ref. 27]. Our observation that 4-HNE
strongly inhibits LRAT activity suggests that the oxidative stress may
contribute to the depletion of retinyl esters in alcoholic liver disease,
because LRAT is believed to be the major enzyme responsible for
esteriﬁcation of retinol in liver [28]. Although some researchers found
no difference in the activity of LRAT in ethanol-fed versus control rats
[29], others reported that the relative amounts of unesteriﬁed retinol
were signiﬁcantly increased in the ethanol-fed rats [30], consistent
with our results.
Although our data suggest that RDH12 can contribute to cell
protection against nonanal, quantitatively nonanal produced as a
result of microsomal membrane peroxidation is a minor product
compared to 4-HNE, which represents more than 95% of the total
unsaturated aldehydes [31–33]. Considering that 4-HNE is muchmore
abundant than nonanal and that RDH12 is not effective for protection
against 4-HNE, it is not surprising that knockout mice that lack RDH12
do not appear to have increased levels of lipid peroxidation products in
the retina [34]. It is well established that there are multiple pathways
for detoxiﬁcation of 4-HNE. In most cells, conjugation of 4-HNE with
glutathione and oxidation to 4-hydroxynonenoic acid are the two
major routes of 4-HNE elimination [35–39]. 4-HNE-GST conjugate can
be further reduced to 1,4-dihydroxy-2-nonene-GST and this reaction
appears to be catalyzed primarily by the cytosolic aldose reductase
[40,41]. The product of direct NADPH-dependent reduction of 4-HNE,
unconjugated 1,4-dihydroxy-2-nonene, which could be potentially
produced by RDH12, constitutes only about ~10–13% of all 4-HNE
metabolites [38,39]. Based on these estimates, the contribution of
RDH12 to detoxiﬁcation of 4-HNE, if any, is rather limited.
Together, these observations suggest that retinaldehyde, not the lipid
peroxidationproducts, is theprimary target of RDH12 inphotoreceptors,
reinforcing the role of RDH12 in retinoidmetabolism. Theﬁnding that 4-
HNE strongly inhibits the biosynthesis of retinyl esters and retinoic acid
suggests that oxidative stress and lipid peroxidation can have
deleterious consequences for the overall retinoid homeostasis in the
cells.
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